These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23852372)

  • 21. Lats2 modulates adipocyte proliferation and differentiation via hippo signaling.
    An Y; Kang Q; Zhao Y; Hu X; Li N
    PLoS One; 2013; 8(8):e72042. PubMed ID: 23977200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.
    Aylon Y; Gershoni A; Rotkopf R; Biton IE; Porat Z; Koh AP; Sun X; Lee Y; Fiel MI; Hoshida Y; Friedman SL; Johnson RL; Oren M
    Genes Dev; 2016 Apr; 30(7):786-97. PubMed ID: 27013235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lats2 phosphorylates p21/CDKN1A after UV irradiation and regulates apoptosis.
    Suzuki H; Yabuta N; Okada N; Torigata K; Aylon Y; Oren M; Nojima H
    J Cell Sci; 2013 Oct; 126(Pt 19):4358-68. PubMed ID: 23886938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
    Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL
    Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways.
    Ma B; Cheng H; Gao R; Mu C; Chen L; Wu S; Chen Q; Zhu Y
    Nat Commun; 2016 Mar; 7():11123. PubMed ID: 27030211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hippo signaling: to die or not to die.
    Aqeilan RI
    Cell Death Differ; 2013 Oct; 20(10):1287-8. PubMed ID: 24013777
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase.
    Ma B; Chen Y; Chen L; Cheng H; Mu C; Li J; Gao R; Zhou C; Cao L; Liu J; Zhu Y; Chen Q; Wu S
    Nat Cell Biol; 2015 Jan; 17(1):95-103. PubMed ID: 25438054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.
    Zhao B; Wei X; Li W; Udan RS; Yang Q; Kim J; Xie J; Ikenoue T; Yu J; Li L; Zheng P; Ye K; Chinnaiyan A; Halder G; Lai ZC; Guan KL
    Genes Dev; 2007 Nov; 21(21):2747-61. PubMed ID: 17974916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP.
    Shi Y; Geng D; Zhang Y; Zhao M; Wang Y; Jiang Y; Yu R; Zhou X
    J Mol Neurosci; 2019 May; 68(1):38-48. PubMed ID: 30771084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.
    Hum M; Tan HJ; Yang Y; Srivastava S; Teh M; Lim YP
    FASEB J; 2021 Feb; 35(2):e21290. PubMed ID: 33475198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Actin-binding and cell proliferation activities of angiomotin family members are regulated by Hippo pathway-mediated phosphorylation.
    Chan SW; Lim CJ; Guo F; Tan I; Leung T; Hong W
    J Biol Chem; 2013 Dec; 288(52):37296-307. PubMed ID: 24225952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage.
    Levy D; Adamovich Y; Reuven N; Shaul Y
    Mol Cell; 2008 Feb; 29(3):350-61. PubMed ID: 18280240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.
    Qin H; Blaschke K; Wei G; Ohi Y; Blouin L; Qi Z; Yu J; Yeh RF; Hebrok M; Ramalho-Santos M
    Hum Mol Genet; 2012 May; 21(9):2054-67. PubMed ID: 22286172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hippo pathway and tumoral FOXP3 expression correlate with tumor growth in squamous cell carcinoma of the lung.
    Won KY; Kim HK; Kim GY; Song MJ; Lim SJ
    Pathol Res Pract; 2020 Jul; 216(7):153003. PubMed ID: 32534707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed activation of Bax by DNA damage in embryonic stem cells with knock-in mutations of the Abl nuclear localization signals.
    Preyer M; Shu CW; Wang JY
    Cell Death Differ; 2007 Jun; 14(6):1139-48. PubMed ID: 17363963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma.
    Guo C; Liang C; Yang J; Hu H; Fan B; Liu X
    Oncol Rep; 2019 May; 41(5):2753-2761. PubMed ID: 30896861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance.
    Guo Y; Cui J; Ji Z; Cheng C; Zhang K; Zhang C; Chu M; Zhao Q; Yu Z; Zhang Y; Fang YX; Gao WQ; Zhu HH
    Oncogene; 2017 Nov; 36(45):6336-6347. PubMed ID: 28745315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LATS2 is a tumor suppressor gene of malignant mesothelioma.
    Murakami H; Mizuno T; Taniguchi T; Fujii M; Ishiguro F; Fukui T; Akatsuka S; Horio Y; Hida T; Kondo Y; Toyokuni S; Osada H; Sekido Y
    Cancer Res; 2011 Feb; 71(3):873-83. PubMed ID: 21245096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ROCK1 knockdown inhibits non-small-cell lung cancer progression by activating the LATS2-JNK signaling pathway.
    Xin T; Lv W; Liu D; Jing Y; Hu F
    Aging (Albany NY); 2020 Jun; 12(12):12160-12174. PubMed ID: 32554853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.